> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss IVD Reclassifications
- URL: https://www.fdaweb.com/panel-to-discuss-ivd-reclassifications/
- Published: 2023-08-14T12:00:00.000Z
- Updated: 2026-09-14T18:50:19.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5155090

*Federal Register* notice: FDA is announcing a 9/7-8 Medical Devices Advisory Committee Microbiology Devices Panel meeting. On 9/7, panel members will discuss and make recommendations regarding a potential future reclassification from Class 3 to Class 2 of nucleic acid and serology-based *in vitro* diagnostic devices indicated for use to aid in diagnosis of hepatitis B virus infection. They will also make recommendations regarding a potential future reclassification from Class 3 to Class 2 of serology-based *in vitro* diagnostic devices indicated for use to aid in detecting human parvovirus B19\. On 9/8, the panel will discuss topics related to *in vitro* diagnostic devices used in pandemic preparedness and response. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-08-14/pdf/2023-17287.pdf?ref=fdaweb.com).